Jing L. has extensive experience in assay development and project management, with a background spanning several prominent companies in the biomedical field. At Roche Molecular Diagnostics, Jing served as Principal Scientist II, leading the development and launch of the KRAS Mutation Test v2 for tissue and plasma samples, while also contributing to RUO and IVD projects. After serving at Roche Sequencing Solutions, where Jing managed the development of AVENIO Tumor Tissue Analysis kits, Jing transitioned to Karius as Senior Director of Assay Development and previously held leadership roles at Freenome, overseeing the Genomics Development team focused on NGS liquid biopsy assays. Academic experience includes a Postdoctoral Research Fellowship at Genentech, concentrating on cancer signal transduction and transcription factor functions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices